These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 9112415

  • 1. Ca2+ or phorbol ester but not inflammatory stimuli elevate inducible nitric oxide synthase messenger ribonucleic acid and nitric oxide (NO) release in avian osteoclasts: autocrine NO mediates Ca2+-inhibited bone resorption.
    Sunyer T, Rothe L, Kirsch D, Jiang X, Anderson F, Osdoby P, Collin-Osdoby P.
    Endocrinology; 1997 May; 138(5):2148-62. PubMed ID: 9112415
    [Abstract] [Full Text] [Related]

  • 2. Proinflammatory agents, IL-8 and IL-10, upregulate inducible nitric oxide synthase expression and nitric oxide production in avian osteoclast-like cells.
    Sunyer T, Rothe L, Jiang X, Osdoby P, Collin-Osdoby P.
    J Cell Biochem; 1996 Mar 15; 60(4):469-83. PubMed ID: 8707887
    [Abstract] [Full Text] [Related]

  • 3. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms.
    Brandi ML, Hukkanen M, Umeda T, Moradi-Bidhendi N, Bianchi S, Gross SS, Polak JM, MacIntyre I.
    Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):2954-8. PubMed ID: 7535933
    [Abstract] [Full Text] [Related]

  • 4. Direct microsensor measurement of nitric oxide production by the osteoclast.
    Silverton SF, Adebanjo OA, Moonga BS, Awumey EM, Malinski T, Zaidi M.
    Biochem Biophys Res Commun; 1999 May 27; 259(1):73-7. PubMed ID: 10334918
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of avian osteoclast bone resorption by monoclonal antibody 121F: a mechanism involving the osteoclast free radical system.
    Collin-Osdoby P, Li L, Rothe L, Anderson F, Kirsch D, Oursler MJ, Osdoby P.
    J Bone Miner Res; 1998 Jan 27; 13(1):67-78. PubMed ID: 9443792
    [Abstract] [Full Text] [Related]

  • 6. Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha.
    Lee SK, Huang H, Lee SW, Kim KH, Kim KK, Kim HM, Lee ZH, Kim HH.
    Exp Cell Res; 2004 Aug 15; 298(2):359-68. PubMed ID: 15265685
    [Abstract] [Full Text] [Related]

  • 7. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
    Mentaverri R, Kamel S, Wattel A, Prouillet C, Sevenet N, Petit JP, Tordjmann T, Brazier M.
    J Cell Biochem; 2003 Apr 15; 88(6):1145-56. PubMed ID: 12647297
    [Abstract] [Full Text] [Related]

  • 8. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption.
    Zheng H, Yu X, Collin-Osdoby P, Osdoby P.
    J Biol Chem; 2006 Jun 09; 281(23):15809-20. PubMed ID: 16613848
    [Abstract] [Full Text] [Related]

  • 9. Tamoxifen inhibits phorbol ester stimulated osteoclastic bone resorption: an effect mediated by calmodulin.
    Williams JP, McKenna MA, Thames AM, McDonald JM.
    Biochem Cell Biol; 2000 Jun 09; 78(6):715-23. PubMed ID: 11206583
    [Abstract] [Full Text] [Related]

  • 10. A possible role for nitric oxide in osteoclastogenesis associated with cholesteatoma.
    Jung JY, Pashia ME, Nishimoto SY, Faddis BT, Chole RA.
    Otol Neurotol; 2004 Sep 09; 25(5):661-8. PubMed ID: 15353992
    [Abstract] [Full Text] [Related]

  • 11. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
    van't Hof RJ, Ralston SH.
    J Bone Miner Res; 1997 Nov 09; 12(11):1797-804. PubMed ID: 9383684
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nitric oxide regulation of cGMP production in osteoclasts.
    Dong SS, Williams JP, Jordan SE, Cornwell T, Blair HC.
    J Cell Biochem; 1999 Jun 15; 73(4):478-87. PubMed ID: 10733342
    [Abstract] [Full Text] [Related]

  • 14. Inducible nitric oxide synthase mediates bone loss in ovariectomized mice.
    Cuzzocrea S, Mazzon E, Dugo L, Genovese T, Di Paola R, Ruggeri Z, Vegeto E, Caputi AP, Van De Loo FA, Puzzolo D, Maggi A.
    Endocrinology; 2003 Mar 15; 144(3):1098-107. PubMed ID: 12586786
    [Abstract] [Full Text] [Related]

  • 15. Expression of nitric oxide synthase isoforms in bone and bone cell cultures.
    Helfrich MH, Evans DE, Grabowski PS, Pollock JS, Ohshima H, Ralston SH.
    J Bone Miner Res; 1997 Jul 15; 12(7):1108-15. PubMed ID: 9200011
    [Abstract] [Full Text] [Related]

  • 16. A human homolog of the 150 kD avian osteoclast membrane antigen related to superoxide dismutase and essential for bone resorption is induced by developmental agents and opposed by estrogen in FLG 29.1 cells.
    Khalkhali-Ellis Z, Collin-Osdoby P, Li L, Brandi ML, Osdoby P.
    Calcif Tissue Int; 1997 Feb 15; 60(2):187-93. PubMed ID: 9056169
    [Abstract] [Full Text] [Related]

  • 17. Bi-directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in J774 macrophages exposed to low and to high concentrations of endotoxin.
    Korhonen R, Kankaanranta H, Lahti A, Lähde M, Knowles RG, Moilanen E.
    Biochem J; 2001 Mar 01; 354(Pt 2):351-8. PubMed ID: 11171114
    [Abstract] [Full Text] [Related]

  • 18. Osteoclast radical interactions: NADPH causes pulsatile release of NO and stimulates superoxide production.
    Silverton SF, Mesaros S, Markham GD, Malinski T.
    Endocrinology; 1995 Nov 01; 136(11):5244-7. PubMed ID: 7588266
    [Abstract] [Full Text] [Related]

  • 19. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium.
    Berger CE, Rathod H, Gillespie JI, Horrocks BR, Datta HK.
    J Bone Miner Res; 2001 Nov 01; 16(11):2092-102. PubMed ID: 11697806
    [Abstract] [Full Text] [Related]

  • 20. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.
    Takami M, Takahashi N, Udagawa N, Miyaura C, Suda K, Woo JT, Martin TJ, Nagai K, Suda T.
    Endocrinology; 2000 Dec 01; 141(12):4711-9. PubMed ID: 11108286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.